Atricure Inc

ATRCNASDAQ · USD
55.95USD+0.93 (+1.69%)
5710

Atricure Inc (ATRC) Covered Calls

Atricure Inc trades in the Medical Instruments & Supplies industry with an IV Rank of 5.56%, low versus the past year. ATRC's highest covered call setup is the $60.00 strike expiring Dec 18, 2026, sorted by theoretical annualized return. It's 8.48% out of the money with 32 days to expiration, a 8.57% return until expiration, and a 97.75% theoretical annualized return. Across the setups shown, annualized returns run from 32.08% to 97.75% at strikes between $60.00 and $70.00, with 32 to 151 days to expiration, as of Nov 16, 2026.

Read more

Running ATRC covered calls helps you generate income from Atricure Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best ATRC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If ATRC stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling ATRC covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given ATRC covered call is worth writing.

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation.

2026-12-183260.008.480.054.90474.008.5797.75-0.09+0.3844.85
2027-04-1615170.0026.560.104.901479.0026.7464.64-0.18+0.2864.80
2027-01-156060.008.480.104.90479.008.6652.68-0.18+0.3804.80
2027-04-1615165.0017.521.555.501124.0020.3249.12-2.80+0.3713.95
2027-04-1615160.008.482.657.50734.0013.2732.08-4.79+0.4774.85

As of Nov 16, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryMedical Instruments & Supplies
  • SectorHealthcare
  • IV Rank5.56% Low
  • Market cap (M$)2,802
  • 52 weeks high-16.66%
  • 52 weeks low116.96%
  • Analyst recommendationBuy
    1.67
  • Target price$66.75
    19.30% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2027-02-16
  • P/E181.23
  • Future P/E116.79
  • EPS (ttm)0.30
  • EPS growth next 5 years—

As of Nov 17, 2026